Market Tracker

01/19 6:29am ET

Acer Therapeutics Inc (NASDAQ:ACER)

19.03
Delayed Data
As of Jan 18
 +0.03 / +0.16%
Today’s Change
5.70
Today|||52-Week Range
22.63
+37.40%
Year-to-Date
No recent news for Acer Therapeutics Inc.

Today’s Trading

Previous close19.00
Today’s open19.10
Day’s range18.88 - 19.40
Volume21,603
Average volume (3 months)30,380
Market cap$140.0M
Data as of 3:59pm ET, 01/18/2018

Growth & Valuation

Earnings growth (last year)+44.88%
Earnings growth (this year)+86.24%
Earnings growth (next 5 years)--
Revenue growth (last year)+13.65%
P/E ratioNM
Price/Sales2.23
Price/Book4.84

Competitors

 Today’s
change
Today’s
% change
EVFMEvofem Biosciences I...+0.60+5.25%
--Achieve Life Science...+0.10+6.58%
MBVXMabVax Therapeutics ...-0.02-2.77%
CPHIChina Pharma Holding...-0.01-2.40%
Data as of 3:59pm ET, 01/18/2018

Financials

Next reporting dateMarch 28, 2018
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$2.9M
Annual profit (last year)-$8.0M
Net profit margin-274.69%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
President, Chief Executive Officer &
Director
Christopher Schelling
Chief Financial Officer
Harry S. Palmin
Corporate headquarters
Cambridge, Massachusetts

Forecasts